🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — need advice Page 12

Pancreatitis risk assessment — need advice

nick_newbie Thu, May 30, 2024 at 12:20 AM 63 replies 3,076 viewsPage 12 of 13
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Jun 16, 2024 at 1:18 PM#56
anna.melb_AU said:
Worth answering the question that was asked rather than the one behind it.

This is my experience too, for whatever a second data point is worth.

44 17Dr.LipidDallas, alex_tucson, kevin_tulsa and 41 others
Reply Quote Save Share Report
nancy_portland
Member
345
1,567
Aug 2024
Portland, ME
Jun 16, 2024 at 11:41 PM#57
anna.melb_AU said:
Worth answering the question that was asked rather than the one behind it.

Coming at anna.melb_AU’s question from a different direction. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

I would rather be corrected than agreed with, if it comes to it.

45 18KristenIndy, MarkLI_maint, Dr.PeteFamMed and 42 others
Reply Quote Save Share Report
marco_milano
Member
345
1,456
Jul 2024
Milan, IT
Jun 17, 2024 at 10:04 AM#58

Found this through search years later and it is still the best discussion of the question, so adding one thing. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

46 19Dr.LipidDallas, alex_tucson, kevin_tulsa and 43 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 17, 2024 at 8:27 PM#59

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

47 20amsterdam_pete, LondonLisa, mike_nyc and 44 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Jun 18, 2024 at 6:50 AM#60
marco_milano said:
Keep the original post as written when you update it, and add the correction underneath.

This is where I part company with the consensus forming above. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

That is the short version; the long version is somebody else's post.

Last edited: Jun 18, 2024 at 12:50 PM
19 17kevin_tulsa, Dr.PainCLE, mike_mealprep and 16 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register